Hamid Hoveyda
Corporate Officer/Principal chez Ogeda SA
Profil
Hamid Hoveyda is currently the Director-Medical Chemistry at Ogeda SA since 2007.
Previously, he worked as a Principal at Affymax, Inc. and Tranzyme Pharma, Inc. (Canada).
Dr. Hoveyda holds a doctorate degree from the University of British Columbia.
Postes actifs de Hamid Hoveyda
| Sociétés | Poste | Début |
|---|---|---|
Ogeda SA
 Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Corporate Officer/Principal | 01/09/2007 |
Anciens postes connus de Hamid Hoveyda
| Sociétés | Poste | Fin |
|---|---|---|
| Tranzyme Pharma, Inc. (Canada) | Corporate Officer/Principal | - |
| AFFYMAX, INC. | Corporate Officer/Principal | - |
Formation de Hamid Hoveyda
| University of British Columbia | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AFFYMAX, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Health Technology |
| Tranzyme Pharma, Inc. (Canada) |
